Median Technologies, a French company founded in 2002, develops AI medical imaging software and imaging services for clinical trials.
Founded in 2002 and headquartered in Sophia Antipolis, France, Median Technologies develops AI, computer vision and signal processing tools for medical imaging. Its eyonis® product, an AI/ML software as a medical device still in development, targets lung and liver cancer, and its Imaging CRO business provides oncology clinical trial imaging to pharmaceutical clients. The company reported revenues of EUR 24,943,419.90 and EBITDA of EUR -23,722,066.90 for 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in